@article{fb0a9d79cb874973851f8f72b8f4ab16,
title = "Comment on Richer et al. Night Vision and Carotenoids (NVC): A Randomized Placebo Controlled Clinical Trial on Effects of Carotenoid Supplementation on Night Vision in Older Adults. Nutrients 2021, 13, 3191",
abstract = "Richer and colleagues [...].",
keywords = "Carotenoids, Dietary Supplements, Night Vision, Nutrients",
author = "Marina Green-Gomez and Warren Roche and Nolan, {John M.}",
note = "Funding Information: Richer and colleagues [1] recently published data in the journal Nutrients, claiming that intervention with a carotenoid supplement containing 14 mg of zeaxanthin and 7 mg of lutein (ScreenShieldPro, Eye Promise) over a 6-month period significantly augments macular pigment (MP) and showed “significant improvements in contrast sensitivity with glare . . . [and] measurable benefits in numerous visual functions that are important for night vision driving . . . ” compared to placebo. As presented in the paper, this trial was funded by Zeavision, the company that sells the ScreenShieldPro carotenoid supplement. Our study of this article strongly disagrees with the results and calls into major question the conclusions made by the authors. Unfortunately, the data presented in the paper are lacking, and we have requested that Richer and colleagues provide us with anonymised sourced data for full analysis. While the data were promised by Richer S., they have not been provided.",
year = "2022",
month = jul,
day = "5",
doi = "10.3390/nu14132769",
language = "English",
volume = "14",
journal = "Nutrients",
issn = "2072-6643",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "13",
}